Brief: Shield Therapeutics Says Fda Approves Accrufer Oral Iron For Children 10 And Older
17/02/2026 20:01
Feb 17 (Reuters) - Shield Therapeutics PLC STXS.L: SHIELD THERAPEUTICS ANNOUNCES FDA APPROVAL OF ACCRUFER®, THE FIRST AND ONLY PRESCRIPTION ORAL IRON THERAPY APPROVED FOR CHILDREN AGE 10 AND OLDER Source text: ID:nPnNl2ZLa Further company coverage: STXS.L ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shield Therapeutics
See all newsBrief: Shield Therapeutics To Assume Full Commercial Control Of ACCRUFeR In US
Shield Therapeutics - Shield assumes full control of ACCRUFeR® in the US
Shield Therapeutics - Interim results for the six months ended 30 Jun 26
Brief: Shield Therapeutics Says On Track For Profitability In 2026; Appoints Michael Jensen As CFO
Shield Therapeutics - Q2 and H1 2026 Trading Update